Literature DB >> 27048483

Current State of Opioid Therapy and Abuse.

Laxmaiah Manchikanti1,2, Adam M Kaye3, Alan D Kaye4.   

Abstract

Currently, there is growing tension between the twin challenges of opioid therapy for chronic pain and adverse consequences of abuse, leading to multiple complications including respiratory failure and death. The recent data from Centers for Disease Control and Prevention (CDC) have shown continued escalation of prescription opioid use with opioid overdose deaths topping all previous estimations. Numerous policy initiatives, advisories, and guidelines have been advanced through the years to control the opioid epidemic. The strategies to prevent opioid abuse and to maintain opioid therapy when medically necessary fall into primary and secondary prevention categories. The primary prevention category is extremely crucial, since it involves education of primary care providers and patients at the starting point of opioid therapy. The education of surgeons and other prescribers is as crucial as the education of primary care physicians.

Entities:  

Keywords:  Abuse resistance opioids; Chronic opioid therapy; Opioid abuse; Opioid adverse consequences; Opioid deaths; Opioid overdoses; Prescription drug monitoring programs (PDMPs)

Mesh:

Substances:

Year:  2016        PMID: 27048483     DOI: 10.1007/s11916-016-0564-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  79 in total

1.  Prescribing opioid analgesics for chronic non-malignant pain in general practice - a survey of attitudes and practice.

Authors:  Holly Blake; Paul Leighton; Gerrie van der Walt; Andrew Ravenscroft
Journal:  Br J Pain       Date:  2015-11

2.  Guidelines warfare over interventional techniques: is there a lack of discourse or straw man?

Authors:  Laxmaiah Manchikanti; Ramsin M Benyamin; Frank J E Falco; David L Caraway; Sukdeb Datta; Joshua A Hirsch
Journal:  Pain Physician       Date:  2012 Jan-Feb       Impact factor: 4.965

3.  Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.

Authors:  Kieran A Slevin; Michael A Ashburn
Journal:  J Opioid Manag       Date:  2011 Mar-Apr

4.  Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.

Authors:  Leonard J Paulozzi; Gail K Strickler; Peter W Kreiner; Caitlin M Koris
Journal:  MMWR Surveill Summ       Date:  2015-10-16

5.  [U.S. Food and Drug Administration (FDA) strengthens warning that non-aspirin non steroidal anti-inflammatory drugs (NSAIDs) can cause myocardial infarctions or strokes: the dentist's perspective].

Authors:  E Rosen; I Tsesis; M Vered
Journal:  Refuat Hapeh Vehashinayim (1993)       Date:  2015-10

6.  Opioids for chronic noncancer pain: still no evidence for superiority of sustained-release opioids.

Authors:  L Pedersen; Oms Fredheim
Journal:  Clin Pharmacol Ther       Date:  2014-12-15       Impact factor: 6.875

7.  Expenditures and health status among adults with back and neck problems.

Authors:  Brook I Martin; Richard A Deyo; Sohail K Mirza; Judith A Turner; Bryan A Comstock; William Hollingworth; Sean D Sullivan
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

Review 8.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

9.  Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain.

Authors:  Christine M Wilder; Shannon C Miller; Elizabeth Tiffany; Theresa Winhusen; Erin L Winstanley; Michael D Stein
Journal:  J Addict Dis       Date:  2016

Review 10.  Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Authors:  Silvia S Martins; Laura Sampson; Magdalena Cerdá; Sandro Galea
Journal:  Am J Public Health       Date:  2015-11       Impact factor: 9.308

View more
  14 in total

1.  Tolerance and cross-tolerance to the antinociceptive effects of oxycodone and the imidazoline I2 receptor agonist phenyzoline in adult male rats.

Authors:  David A Thorn; Yanan Zhang; Jun-Xu Li
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

Review 2.  Utilization of Facet Joint and Sacroiliac Joint Interventions in Medicare Population from 2000 to 2014: Explosive Growth Continues!

Authors:  Laxmaiah Manchikanti; Joshua A Hirsch; Vidyasagar Pampati; Mark V Boswell
Journal:  Curr Pain Headache Rep       Date:  2016-10

3.  Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

Authors:  J Douglas Thornton; Elizabeth Lyvers; Virginia Ginger G Scott; Nilanjana Dwibedi
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-02

4.  Bacopa monnieri attenuates glutamate-induced nociception and brain mitochondrial toxicity in Zebrafish.

Authors:  Mahima Sharma; Pankaj Gupta; Debapriya Garabadu
Journal:  Metab Brain Dis       Date:  2021-11-24       Impact factor: 3.584

Review 5.  Pain States, the Opioid Epidemic, and the Role of Radiologists.

Authors:  Mark R Jones; Alan D Kaye; Laxmaiah Manchikanti; Joshua A Hirsch
Journal:  Curr Pain Headache Rep       Date:  2018-02-23

6.  Cost Utility Analysis of Cervical Therapeutic Medial Branch Blocks in Managing Chronic Neck Pain.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Int J Med Sci       Date:  2017-10-15       Impact factor: 3.738

Review 7.  Targeting practitioners: A review of guidelines, training, and policy in pain management.

Authors:  Kelly S Barth; Constance Guille; Jenna McCauley; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2017-04-01       Impact factor: 4.492

8.  Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation.

Authors:  M Mofizul Islam; Ian S McRae; Soumya Mazumdar; Paul Simpson; Dennis Wollersheim; Kaniz Fatema; Tony Butler
Journal:  BMC Pharmacol Toxicol       Date:  2018-06-18       Impact factor: 2.483

9.  Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review.

Authors:  Nicoleta Stoicea; Andrew Costa; Luis Periel; Alberto Uribe; Tristan Weaver; Sergio D Bergese
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  Therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain: cost utility analysis based on a randomized controlled trial.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Korean J Pain       Date:  2018-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.